tyrphostin a23 has been researched along with Respiratory Distress Syndrome in 1 studies
tyrphostin A23: inhibits EGF-stimulated thymidine incorporation as well as EGF-stimulated receptor autophosphorylation & tyrosine phosphorylation & cell proliferation; structure given in first source
Respiratory Distress Syndrome: A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Severgnini, M | 1 |
| Takahashi, S | 1 |
| Tu, P | 1 |
| Perides, G | 1 |
| Homer, RJ | 1 |
| Jhung, JW | 1 |
| Bhavsar, D | 1 |
| Cochran, BH | 1 |
| Simon, AR | 1 |
1 other study available for tyrphostin a23 and Respiratory Distress Syndrome
| Article | Year |
|---|---|
Inhibition of the Src and Jak kinases protects against lipopolysaccharide-induced acute lung injury.
Topics: Adenoviridae; Animals; Capillary Leak Syndrome; Enzyme Activation; Enzyme Inhibitors; Escherichia co | 2005 |